Polar Capital Global Healthcare - Initiation from QuotedData
5th March 2024
Healthy returns and a rosy outlook
Polar Capital Global Healthcare (PCGH) is, as we show on page 17, the leading performer within its peer group over the long term. Its managers' high-conviction approach and good stock-picking skills have helped it navigate a period of relative underperformance by the healthcare sector. The managers feel that the sector is overdue a re-rating.
PCGH's managers point to the long-term trends that are driving growing demand for healthcare (see page 5). Higher utilisation of healthcare is fuelling revenue growth for companies exposed to the sector and encouraging developments in areas such as the way in which healthcare is delivered and the take-up of preventative medicine. Innovative drugs and medical technologies are opening up new frontiers for the sector. Cheap valuations, especially amongst small-cap and biotech names, are encouraging mergers and acquisitions (M&A) activity. All of this points to a rosy long-term outlook for the sector, which PCGH is well-positioned to benefit from.
Full Research:
https://quoteddata.com/research/polar-capital-global-healthcare-healthy-returns-rosy-outlook-qd/
This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.
NB: Marten & Co was paid to produce this note on Polar Capital Global Healthcare Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.
QUOTEDDATA
50 Gresham Street | London EC2V 7AY
Tel: +44 (0) 20 3691 9430
www.quoteddata.com | research@quoteddata.com | www.martenandco.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
